Hospital Acquired Infections Market Size, Share & Forecast USD 19.5 Bn by 2030 | Global Industry Analysis

The Global Hospital Acquired Infections Market size reached USD 14.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 19.5 billion by 2030. The global hospital acquired infections market is expected to exhibit a CAGR of 3.8% during the forecast period 2023-2030.

The Hospital Acquired Infections Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale confidently, and capitalize on the right opportunities in an ever-evolving landscape.

Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/hospital-acquired-infections-market?kb

Hospital Acquired Infections Market Overview

Hospital-acquired infections (HAIs), also known as nosocomial infections, are infections that patients develop during their stay in a healthcare facility, typically 48 hours or more after admission. These infections are not present or incubating at the time of admission and often result from exposure to bacteria, viruses, or fungi in clinical environments. Common types include urinary tract infections, surgical site infections, bloodstream infections, and pneumonia.

Research Methodology:

The global Hospital Acquired Infections Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.

Segment Covered in the Hospital Acquired Infections Market:

by Infection Type: Gastrointestinal Infections, Ventilator Associated Pneumonia, Urinary Tract Infections, Surgical Site Infections, Bloodstream Infections, Others

By End User: Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers, Others

By Drug Type: Antibacterial Drug, Antiviral Drug, Antifungal Drug, Others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hospital-acquired-infections-market?kb

List of the Key Players in the Hospital Acquired Infections Market:

F Hoffmann-la Roche Ltd, Pfizer Inc., AbbVie Inc., AstraZeneca, GSK plc, Innoviva, ELI LILLY AND COMPANY, STERIS, Cipla Inc. and Basilea Pharmaceutica Ltd. among others.

Industry Development:

On May 23, 2023, the U.S. Food and Drug Administration (FDA) approved XACDURO a combination of durlobactam and sulbactam for injection-for intravenous use in adults aged 18 and older. This treatment is indicated for ventilator-associated bacterial pneumonia (VABP) and hospital-acquired bacterial pneumonia (HABP) caused by susceptible strains of the Acinetobacter baumannii-calcoaceticus complex. Innoviva Specialty Therapeutics aims to deliver advanced solutions for infectious diseases and critical care management.

Regional Analysis for Hospital Acquired Infections Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Go-to-market Strategy.

➡ Neutral perspective on the market performance.

➡ Customized regional/country reports as per request and country level analysis.

➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Hospital Acquired Infections market?

➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?

➠ What key opportunities and challenges do vendors face in the Hospital Acquired Infections industry?

➠ Which product types, applications, or end-users are driving market growth, and what is their market share?

➠ What are the major growth drivers and restraints of the Hospital Acquired Infections market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.